HER2 Trastuzumab Biosimilar anti-Human, Unconjugated, Clone: Trastuzumab.rMAb (also known as Trastuzumab Biosimilar), BD Phrmingen™

Biosimilar Monoclonal Antibody

Supplier:  BD Biosciences 569599

Catalog No. BDB569599

Description

HER2 Trastuzumab Biosimilar Monoclonal antibody specifically detects HER2 Trastuzumab Biosimilar in Human samples. It is validated for Flow cytometry|Inhibition

Specifications

• Antigen: HER2 Trastuzumab Biosimilar
• Classification: Monoclonal
• Concentration: 1.0 mg/mL
• Formulation: No azide/low endotoxin: Aqueous buffered solution containing no preservative, 0.2 μm sterile filtered. Endotoxin level is ≤0.01 EU/μg (≤0.001 ng/μg) of protein as determined by the LAL assay.
• Immunogen: A431 Cell Line Expressing EGFR
• Quantity: 0.5 mg
• Primary or Secondary: Primary
• Target Species: Human
• Form: Liquid

• Applications: Flow Cytometry, Inhibition Assays
• Clone: Trastuzumab.rMAb (also known as Trastuzumab Biosimilar)
• Conjugate: Unconjugated
• Gene Alias: ERBB2; proto-oncogene c-ErbB-2; HER-2; HER2; HER-2/neu; NEU; CD340
• Purification Method: Affinity Chromatography
• Regulatory Status: RUO
• Gene ID (Entrez): 2064
• Content And Storage: Store undiluted at 4°C. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. This preparation contains no preservatives, thus it should be handled under aseptic conditions.
• Isotype: IgG1 κ